Development and External Validation of an Extended Repeat Biopsy Nomogram

Journal of Urology

Volumn 177, Issue 2, 2007, Pages 510-515

  Chun, Felix K H ^a   Briganti, Alberto ^a   Graefen, Markus ^b   Porter, Christopher ^c   Montorsi, Francesco ^d   Haese, Alexander ^b   Scattoni, Vincenzo ^d   Borden, Lester ^c   Steuber, Thomas ^b   Salonia, Andrea ^d   Schlomm, Thorsten ^b   Latchemsetty, Kalyan ^c   Walz, Jochen ^b   Kim, Jason ^c   Eichelberg, Christian ^b   Currlin, Eike ^b   Ahyai, Sascha A ^b   Erbersdobler, Andreas ^b   Valiquette, Luc ^a   Heinzer, Hans ^b   Rigatti, Patrizio ^d   Huland, Hartwig ^b   Karakiewicz, Pierre I ^a   more..

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITY OF HAMBURG   (Germany)

^c VIRGINIA MASON MEDICAL CENTER   (United States)

^d VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

biopsy; nomograms; prostate; prostatic neoplasms

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGE DISTRIBUTION; AGED; ANTIGEN DETECTION; ARTICLE; BIOCHEMISTRY; CANCER DIAGNOSIS; CLINICAL FEATURE; COHORT ANALYSIS; DIAGNOSTIC ACCURACY; DIGITAL RECTAL EXAMINATION; EUROPE; GERMANY; HUMAN; HUMAN TISSUE; ITALY; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NOMOGRAM; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATE TUMOR; RACE DIFFERENCE; UNITED STATES; VALIDATION STUDY;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY; HUMANS; MALE; MIDDLE AGED; NOMOGRAMS; PROSTATIC NEOPLASMS;

EID: 33846001375     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2006.09.025     Document Type: Article

References (20)

1. Jemal A., Ward E., Hao Y., and Thun M. Trends in the leading causes of death in the United States, 1970-2002. JAMA 294 (2005) 1255
2. Borboroglu P.G., Comer S.W., Riffenburgh R.H., and Amling C.L. Extensive repeat transrectal ultrasound guided prostate biopsy in patients with previous benign sextant biopsies. J Urol 163 (2000) 158
3. Djavan B., Zlotta A., Remzi M., Ghawidel K., Basharkhah A., Schulman C.C., et al. Optimal predictors of prostate cancer on repeat prostate biopsy: a prospective study in 1,051 men. J Urol 163 (2000) 1144
4. Stewart C.S., Leibovich B.C., Weaver A.L., and Lieber M.M. Prostate cancer diagnosis using a saturation needle biopsy technique after previous negative sextant biopsies. J Urol 166 (2001) 86
5. Rabets J.C., Jones J.S., Patel A., and Zippe C.D. Prostate cancer detection with office based saturation biopsy in a repeat biopsy population. J Urol 172 (2004) 94
6. Fleshner N., and Klotz L. Role of "saturation biopsy" in the detection of prostate cancer among difficult diagnostic cases. Urology 60 (2002) 93
7. Lopez-Corona E., Ohori M., Scardino P.T., Reuter V.E., Gonen M., and Kattan M.W. A nomogram for predicting a positive repeat prostate biopsy in patients with a previous negative biopsy session. J Urol 170 (2003) 1184
8. Yanke B.V., Gonen M., Scardino P.T., and Kattan M.W. Validation of a nomogram for predicting positive repeat biopsy for prostate cancer. J Urol 173 (2005) 421
9. Eskew L.A., Bare R.L., and McCullough D.L. Systematic 5 region prostate biopsy is superior to sextant method for diagnosing carcinoma of the prostate. J Urol 157 (1997) 199
10. Gerstenbluth R.E., Seftel A.D., Hampel N., Oefelein M.G., and Resnick M.I. The accuracy of the increased prostate specific antigen level (greater than or equal to 20 ng./ml.) in predicting prostate cancer: is biopsy always required?. J Urol 168 (2002) 1990
11. Haggman M.J., Adolfsson J., Khoury S., Montie J.E., and Norlen J. Clinical management of premalignant lesions of the prostate. WHO Collaborative Project and Consensus Conference Public Health and Clinical Significance of Premalignant Alterations in the Genitourinary Tract. Scand J Urol Nephrol Suppl 205 (2000) 44
12. O'Dowd G.J., Miller M.C., Orozco R., and Veltri R.W. Analysis of repeated biopsy results within 1 year after a noncancer diagnosis. Urology 55 (2000) 553
13. Remzi M., Anagnostou T., Ravery V., Zlotta A., Stephan C., Marberger M., et al. An artificial neural network to predict the outcome of repeat prostate biopsies. Urology 62 (2003) 456
14. Uzzo R.G., Wei J.T., Waldbaum R.S., Perlmutter A.P., Byrne J.C., and Vaughan Jr. E.D. The influence of prostate size on cancer detection. Urology 46 (1995) 831
15. Remzi M., Djavan B., Wammack R., Momeni M., Seitz C., Erne B., et al. Can total and transition zone volume of the prostate determine whether to perform a repeat biopsy?. Urology 61 (2003) 161
16. Remzi M., Fong Y.K., Dobrovits M., Anagnostou T., Seitz C., Waldert M., et al. The Vienna nomogram: validation of a novel biopsy strategy defining the optimal number of cores based on patient age and total prostate volume. J Urol 174 (2005) 1256
17. Suzuki H., Komiya A., Kamiya N., Imamoto T., Kawamura K., Miura J., et al. Development of a nomogram to predict probability of positive initial prostate biopsy among Japanese patients. Urology 67 (2006) 131
18. Epstein J.I., and Potter S.R. The pathological interpretation and significance of prostate needle biopsy findings: implications and current controversies. J Urol 166 (2001) 402
19. Roscigno M., Scattoni V., Freschi M., Raber M., Colombo R., Bertini R., et al. Monofocal and plurifocal high-grade prostatic intraepithelial neoplasia on extended prostate biopsies: factors predicting cancer detection on extended repeat biopsy. Urology 63 (2004) 1105
20. Specht M.C., Kattan M.W., Gonen M., Fey J., and Van Zee K.J. Predicting nonsentinel node status after positive sentinel lymph biopsy for breast cancer: clinicians versus nomogram. Ann Surg Oncol 12 (2005) 654